Resultados de la búsqueda 141-150 of 18825 for Two-phase

  1. Oncología (médica) - Ensayos clínicos

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. ... The study will be performed in two phases: Phase I will be ...

  2. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

  4. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  5. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... The study will be performed in two phases: Phase I will be performed ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

  7. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...

  9. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... The study will be performed in two phases: Phase I will be performed ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...